Skip to main content

Bone and Soft Tissue Pathology from Head to Toe: An Anatomical Approach

Original release date:
January 10, 2022
Access to this course expires on:  November 18, 2024 at 11:59 PM Pacific Time
CME 10.75

Course Description
Bone and soft tissue pathology is challenging, even for experienced surgical pathologists. Mesenchymal tumors are rare, show a wide morphologic spectrum with significant histologic overlap between benign and malignant tumors and between mesenchymal and non-mesenchymal tumors. Moreover, the classification of bone and soft tissue tumors continues to evolve with rare "new" entities being described with ever-increasing frequency on the basis of distinctive molecular or histologic features. As the field grows more complex, surgical pathologists may struggle to stay up to date with new entities, changes in staging guidelines, recently developed immunohistochemical and molecular diagnostic tests, and may therefore struggle with accurate diagnosis. To help resolve these issues and update your current knowledge, USCAP is offering a unique mentoring opportunity with experienced educators who can help you focus on these updates through interactive dialogue and shared exemplary cases.

Target Audience
Practicing academic and community pathologists, and pathologists-in-training

Learning Objectives
Upon completion of this educational activity, learners will be able to:
  • Develop a differential diagnosis for bone and soft tissue tumors based on anatomic site and histologic patterns
  • Apply immunohistochemical studies to resolve the differential diagnoses of mesenchymal tumors
  • Understand the role and limitations of diagnostic molecular studies in the diagnosis of mesenchymal tumors

Continuing Medical Education
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 10.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any financial relationship(s) that have occurred within the last 24 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and mitigated all identified conflicts of interest, as applicable.

The following faculty and IM Coordinator reported no relevant financial relationships: Elizabeth G. Demicco, MD, PhD , Rajiv M. Patel, MD, Jorge Torres-Mora, MD, Wei-Lien (Billy) Wang, MD

USCAP staff associated with the development of content for this activity reported no relevant financial relationships.

To earn CME credit, all learners must complete the evaluation. View and print your certificate by clicking here.

Buy the entire course and get a great discount! Not A Member? Click Here